Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
Showing 301 - 320 results of 7,211 for search '(( significantly higher decrease ) OR ( significantly ((alter decrease) OR (greater decrease)) ))', query time: 0.27s Refine Results
  1. 301
    Disruption of hepatic metabolism in Lep KO mice.

    Disruption of hepatic metabolism in Lep KO mice. by Yu Sang Choi (22656230)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 302
    Composition of the gut microbiota at the phylum level following the administration of MP.

    Composition of the gut microbiota at the phylum level following the administration of MP. by Yu Sang Choi (22656230)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 303
    Comparison of (a) Chao index and (b) Shannon diversity index of the fecal microbiota in WT and Lep KO mice.

    Comparison of (a) Chao index and (b) Shannon diversity index of the fecal microbiota in WT and Lep KO mice. by Yu Sang Choi (22656230)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 304
    Global transcriptional analysis for activated gametocytes of Δ<i>pbpp6</i> parasites by RNA-seq.

    Global transcriptional analysis for activated gametocytes of Δ<i>pbpp6</i> parasites by RNA-seq. by Yonghui Feng (12227596)

    Published 2025
    Save to List
    Saved in:
  5. 305
    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases.

    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 306
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 307
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 308
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 309
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 310
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 311
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 312
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 313
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 314
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 315
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 316
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 317
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 318
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 319
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 320
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: